AI assistant
Novonesis AS — Director's Dealing 2011
May 31, 2011
3377_rpt_2011-05-31_815f5a9c-2e22-4d44-be50-0c452931c2ff.pdf
Director's Dealing
Open in viewerOpens in your device viewer
May 31, 2011
In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0010272129, Novozymes B shares under the symbol NZYM B.
| Name | Relation/ Category of close relation |
Trading date | Character of transaction |
Volume of transaction Buy (+) / Sell (-) |
Value of trans action (DKK) |
|---|---|---|---|---|---|
| Peder Holk Nielsen | EVP, Enzyme Business |
30/5/2011 | Sale of shares | -3,798 | 3,307,511 |
Contact persons: Press and media: Investor relations: René Tronborg (Europe) Tel. (direct): +45 4446 2274 Tel. (mobile): +45 3077 2274
Paige Donnelly (USA) Tel. (direct): +1 919 494 3209 Tel. (mobile): +1 919 218 4501
Tobias Bjorklund Tel. (direct): +45 4446 8682 Tel. (mobile): +45 3077 8682
Martin Riise Nielsen Tel. (direct): +45 4446 0738 Tel. (mobile): +45 3077 0738
Thomas Bomhoff (USA) Tel. (direct): +1 919 494 3483 Tel. (mobile): +1 919 649 2565
Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.
Company announcement no. 38, 2011 Page 1 of 1 Novozymes A/S Investor Relations
Krogshoejvej 36 2880 Bagsvaerd Denmark
Telephone: +45 4446 0000 Fax: +45 4446 9999 Internet: www.novozymes.com CVR number: 10 00 71 27